Sanofi-Aventis Fails To Kill FCA Suit Over Lovenox

Law360, Los Angeles (May 13, 2014, 5:48 PM ET) -- A California federal judge on Tuesday declined to give Sanofi-Aventis SA an early escape from rival Amphastar Pharmaceutical Inc.’s False Claims Act suit alleging the company fraudulently inflated the price of its anticoagulant drug Lovenox, ruling Amphastar had properly disclosed information to the government before filing.

U.S. District Judge Marvin J. Garbis denied Sanofi-Aventis’ motion for summary judgment for lack of jurisdiction. The company had argued that Amphastar’s prefiling disclosure letter to the government was only a summary of allegations it intended to make and did not reveal...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Amphastar Pharmaceuticals Inc v. Aventis Pharma SA et al


Case Number

5:09-cv-00023

Court

California Central

Nature of Suit

Patent

Judge

Marvin J. Garbis

Date Filed

January 6, 2009

Law Firms

Companies

Government Agencies

Patents